Literature DB >> 11425952

Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2.

J M Gijtenbeek1, A A Gabreëls-Festen, M Lammens, M J Zwarts, B G van Engelen.   

Abstract

The authors report a patient with neurofibromatosis type 2 (NF2) presenting with an axonal mononeuropathy multiplex. Sural nerve biopsy showed small scattered groups of Schwann cells transformed into irregular branching cells with abnormal cell-cell contacts. The authors hypothesize that defective Schwann cell function, due to inactivation of the NF2 gene product merlin, leads to changes in morphology, cell-cell contact, and growth, and finally to degeneration of axons.

Entities:  

Mesh:

Year:  2001        PMID: 11425952     DOI: 10.1212/wnl.56.12.1766

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

Review 1.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

2.  Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.

Authors:  Michael S Dirks; John A Butman; H Jeffrey Kim; Tianxia Wu; Keaton Morgan; Anne P Tran; Russell R Lonser; Ashok R Asthagiri
Journal:  J Neurosurg       Date:  2012-04-13       Impact factor: 5.115

3.  Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy.

Authors:  P Bäumer; V F Mautner; T Bäumer; M U Schuhmann; M Tatagiba; S Heiland; T Kaestel; M Bendszus; M Pham
Journal:  J Neurol       Date:  2012-07-04       Impact factor: 4.849

Review 4.  A neuronal function of the tumor suppressor protein merlin.

Authors:  Alexander Schulz; Ansgar Zoch; Helen Morrison
Journal:  Acta Neuropathol Commun       Date:  2014-07-12       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.